Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response.
Advancements in molecular biology have unveiled multiple breast cancer promoting pathways and potential therapeutic targets.Large randomized clinical trials remain the ultimate means of validating therapeutic efficacy, but they require large cohorts of patients and are lengthy and costly.A useful approach is to conduct a window of opportunity study